SKID
DEVICE
Skin Care Detector: smart skin analysis – fast, precise, and personalized.
SKID revolutionizes skincare by combining autofluorescence technology with artificial intelligence to deliver fast, cost-effective, and non-invasive skin analysis. Designed for consumers, cosmetic professionals, and dermatologists, SKID precisely determines skin biotypes, personalizes treatments, and enables early diagnosis of skin conditions. By utilizing a specialized light source, it overcomes the complexity and high costs of traditional methods, making advanced skin assessment more accessible and accurate than ever before.
Project Status
Status: SKID is in the experimental phase, with promising preliminary results in the detection of skin biotypes via autofluorescence. A patent application covering the technology has been filed and is currently under examination. We are refining the AI algorithm and conducting further tests to validate the system, with plans for future deployments and collaborations.
Frequently asked questions
What does SKID do?
SKID — Skin Care Detector — determines skin biotypes non-invasively by combining skin autofluorescence with machine learning. It is designed for consumers, cosmetic professionals and dermatologists, to personalise treatments and support the early detection of skin conditions. It is developed at the Metabolic Intelligence Lab of Università Cattolica del Sacro Cuore in Rome.
Why autofluorescence?
Because skin emits its own fluorescence signal, which changes with the biochemical state of the tissue. Reading that signal needs no dye, no biopsy and no contact with the skin: the measurement is fast, low-cost and repeatable.
Is SKID available, and is it a medical device?
Neither yet. SKID is in the experimental phase, with promising preliminary results on biotype detection; a patent application has been filed and is under examination, and the AI algorithm is still being refined and validated. It is not a certified diagnostic device and is not on the market.
Who can collaborate on it?
The lab works with cosmetic and dermatology partners on validation studies and future deployments. Enquiries go through the contacts page.
The full publication list behind this work is on the Publications page.